Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 28, 2005; 11(16): 2390-2397
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2390
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2390
Probe Set ID | T vs C SLR | P vs C SLR | Name | GO molecular function |
201655-s-at | 3.1 | 2.6 | Heparan sulfate | GO:5198; structural molecule activity; inferred from electronic annotation |
proteoglycan 2 (perlecan) | GO:5206; heparin sulfate proteoglycan; traceable author statement | |||
201890-at | 3.1 | 1.6 | Ribonucleotide reductase | GO:4748; ribonucleoside-diphosphate reductase activity;non-traceable |
M2 polypeptide | author statement | |||
GO:16491; oxidoreductase activity; inferred from electronic annotation | ||||
201926-s-at | 3.1 | 1 | Decay accelerating factor for complement (CD55, Cromer blood group system) | Unknown |
203334-at | 3.1 | 3.8 | DEAD/H (Asp-Glu-Ala—Asp/His) box polypeptide 8(RNA helicase) | GO:3723; RNA binding; inferred from electronic annotation |
GO:8248; pre-mRNA splicing factor activity; traceable author statement | ||||
GO:5524; ATP binding;inferred from electronic annotation | ||||
GO:4004; ATP dependent RNA helicase activity; traceable author statement | ||||
202870-s-at | 3.3 | 1.5 | CDC20 cell division cycle 20 homolog (S. cerevisiae) | Unknown |
209035-at | 3.3 | 1.6 | Midkine (neurite growth- promoting factor 2) | GO:8201; heparin binding; not recorded |
GO:8083; growth factor activity; not recorded | ||||
GO:5125; cytokine activity; not recorded | ||||
209803-s-at | 3.4 | 1.8 | Tumor suppressing subtransferable candidate 3 | Unknown |
212444-at | 3.4 | 1.2 | Homo sapiens, clone IMAGE:4471726, mRNA | Unknown |
217173-s-at | 3.4 | 3.6 | Low density lipoprotein receptor (familial hypercholesterolemia) | GO:5041; low-density lipoprotein receptor activity; traceable author statement |
GO:5509; calcium ion binding; inferred from electronic annotation | ||||
GO:8034; lipoprotein binding; traceable author statement | ||||
GO:5319; lipid transporter activity; inferred from electronic | ||||
217221-x-at | 3.5 | 2.2 | RNA binding motif protein 10 | GO:3676; rrm; nucleic acid binding activity; 8.4e-05; extended: inferred from electronic annotation |
GO:3676; rrm; nucleic acid binding activity; 0.76; extended: inferred from electronic annotation | ||||
202855-s-at | 3.6 | 1.2 | Solute carrier family 16 (monocarboxylic acid transporters), member 3 | GO:8028; monocarboxylic acid transporter activity; traceable author statement |
GO:15355; monocarboxylate porter activity; inferred from electronic annotation | ||||
GO:15293; symporter activity; inferred from electronic annotation | ||||
203559-s-at | 3.6 | 1.2 | Amiloride binding protein 1(amine oxidase (copper-containing)) | GO:8144; drug binding;not recorded |
GO:8201; heparin binding; inferred from electronic annotation | ||||
GO:8122; amine oxidase (copper-containing) activity; inferred from electronic annotation | ||||
GO:16491; oxidoreductase activity; inferred from electronic annotation | ||||
209373-at | 3.8 | 1.6 | BENE protein | Unknown |
203108-at | 4.2 | 1.5 | Retinoic acid induced 3 | GO:8067; metabotropic glutamate, GABA-B-like receptor activity; inferred from electronic annotation |
GO:4872; receptor activity; inferred from electronic annotation | ||||
202067-s-at | 4.5 | 3.8 | Low density lipoprotein receptor (familial hypercholesterolemia) | GO:5041; low-density lipoprotein receptor activity; traceable author statement |
GO:5509; calcium ion binding; inferred from electronic annotation | ||||
GO:8034; lipoprotein binding; traceable author statement | ||||
GO:5319; lipid transporter activity; inferred from electronic | ||||
218900-at | 4.5 | 3.7 | Cyclin M4 | Unknown |
201884-at | 4.6 | 2.1 | Carcinoembryonic antigen-related cell adhesion molecule 5 | GO:8222; tumor antigen; traceable author statement |
211657-at | 5.9 | 2.1 | Carcinoembryonic antigen- related cell adhesion molecule 6 | GO:8222; tumor antigen; traceable author statement |
212768-s-at | 4.7 | 1.3 | Differentially expressed in hematopoietic lineages | Unknown |
208250-s-at | 6.3 | 1.7 | Deleted in malignant brain tumors 1 | GO:8181; tumor suppressor; predicted/computed |
GO:5044; SRCR; scavenger receptor activity; 3.7e-42;extended: unknown | ||||
204855-at | 7.7 | 4.2 | Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin) member 5 | GO:4868; serpin; not recorded GO:4867; serine protease nhibitor activity; inferred from electronic annotation |
GO:8181; tumor suppressor; traceable author statement serp |
- Citation: Yu CD, Xu SH, Mou HZ, Jiang ZM, Zhu CH, Liu XL. Gene expression profile differences in gastric cancer, pericancerous epithelium and normal gastric mucosa by gene chip. World J Gastroenterol 2005; 11(16): 2390-2397
- URL: https://www.wjgnet.com/1007-9327/full/v11/i16/2390.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i16.2390